- Home
- EKSO vs TXMD Comparison
EKSO vs TXMD Comparison
Compare EKSO & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EKSO | TXMD |
|---|---|---|
| Founded | 2005 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.2M | 25.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EKSO | TXMD |
|---|---|---|
| Price | $7.27 | $2.31 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $9.50 | N/A |
| AVG Volume (30 Days) | ★ 5.9M | 142.1K |
| Earning Date | 03-02-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $14,749,000.00 | $2,796,000.00 |
| Revenue This Year | N/A | $427.09 |
| Revenue Next Year | $54.65 | N/A |
| P/E Ratio | ★ N/A | $95.81 |
| Revenue Growth | N/A | ★ 75.19 |
| 52 Week Low | $2.73 | $0.72 |
| 52 Week High | $12.70 | $2.59 |
Technical Indicators
Market Signals| Indicator | EKSO | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 48.80 | 70.54 |
| Support Level | $7.70 | $2.16 |
| Resistance Level | $9.11 | $2.59 |
| Average True Range (ATR) | 1.09 | 0.22 |
| MACD | -0.17 | 0.05 |
| Stochastic Oscillator | 1.29 | 80.18 |
Price Performance
Historical ComparisonAbout EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.